Zhou Alex-Xianghua, Jeansson Marie, He Liqun, Wigge Leif, Tonelius Pernilla, Tati Ramesh, Cederblad Linda, Muhl Lars, Uhrbom Martin, Liu Jianping, Björnson Granqvist Anna, Lerman Lilach O, Betsholtz Christer, Hansen Pernille B L
Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, 43162 Mölndal, Sweden.
Department of Medicine Huddinge, Karolinska Institutet, 141 52 Huddinge, Sweden.
Int J Mol Sci. 2024 Apr 13;25(8):4320. doi: 10.3390/ijms25084320.
Endothelial cell (EC) injury is a crucial contributor to the progression of diabetic kidney disease (DKD), but the specific EC populations and mechanisms involved remain elusive. Kidney ECs ( = 5464) were collected at three timepoints from diabetic BTBR mice and non-diabetic littermates. Their heterogeneity, transcriptional changes, and alternative splicing during DKD progression were mapped using SmartSeq2 single-cell RNA sequencing (scRNAseq) and elucidated through pathway, network, and gene ontology enrichment analyses. We identified 13 distinct transcriptional EC phenotypes corresponding to different kidney vessel subtypes, confirmed through in situ hybridization and immunofluorescence. EC subtypes along nephrons displayed extensive zonation related to their functions. Differential gene expression analyses in peritubular and glomerular ECs in DKD underlined the regulation of DKD-relevant pathways including EIF2 signaling, oxidative phosphorylation, and IGF1 signaling. Importantly, this revealed the differential alteration of these pathways between the two EC subtypes and changes during disease progression. Furthermore, glomerular and peritubular ECs also displayed aberrant and dynamic alterations in alternative splicing (AS), which is strongly associated with DNA repair. Strikingly, genes displaying differential transcription or alternative splicing participate in divergent biological processes. Our study reveals the spatiotemporal regulation of gene transcription and AS linked to DKD progression, providing insight into pathomechanisms and clues to novel therapeutic targets for DKD treatment.
内皮细胞(EC)损伤是糖尿病肾病(DKD)进展的关键因素,但具体涉及的EC群体和机制仍不清楚。在三个时间点从糖尿病BTBR小鼠和非糖尿病同窝小鼠中收集肾EC(n = 5464)。使用SmartSeq2单细胞RNA测序(scRNAseq)绘制它们在DKD进展过程中的异质性、转录变化和可变剪接,并通过通路、网络和基因本体富集分析进行阐明。我们鉴定出13种不同的转录EC表型,对应于不同的肾血管亚型,通过原位杂交和免疫荧光得到证实。沿肾单位的EC亚型显示出与其功能相关的广泛分区。对DKD中肾小管周围和肾小球EC的差异基因表达分析强调了与DKD相关通路(包括EIF2信号传导、氧化磷酸化和IGF1信号传导)的调控。重要的是,这揭示了这两种EC亚型之间这些通路的差异改变以及疾病进展过程中的变化。此外,肾小球和肾小管周围EC在可变剪接(AS)中也表现出异常和动态变化,这与DNA修复密切相关。引人注目的是,显示差异转录或可变剪接的基因参与不同的生物学过程。我们的研究揭示了与DKD进展相关的基因转录和AS的时空调控,为DKD的发病机制提供了见解,并为新的治疗靶点提供了线索。